Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese
Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese
Abstract Background Recent studies identified an increased risk of prostate cancer (PCa) in Caucasian men harboring polymorphisms of genes involved in innate immunity and inflammation. This study was designed to assess whether single nucleotide polymorphisms in the IL-10 promoter play a role in predisposing individuals to PCa in a Chinese population. Methods We genotyped three SNPs of the IL-10 promoter (-1082A/G, -819T/C and -592A/C) using polymerase chain reaction-restriction fragment length polymorphism analysis in 262 subjects with PCa and 270 age-matched healthy controls. Odds ratio and 95% confidence interval were determined by logistic regression for the associations between IL-10 genotypes and haplotypes with the risk of PCa and advanced PCa grade. Results No significant differences in allele frequency or genotype distribution were observed for any of the IL-10 SNPs between PCa patients and control subjects. Significantly higher frequencies of -1082G, -819C and -592C allele and GCC haplotype were observed, however, in early stage patients in comparison to advanced PCa patients (for -1082 G, 13.9% vs 6.1%, OR = 2.48, P = 0.005; for -819 C 40.3% vs 30.8%, OR = 1.51, P = 0.043; for -512C, 40.3% vs 30.8%, OR = 1.51, P = 0.043; and for haplotype GCC 11.1%vs 5.1%, OR = 2.66, P = 0.008, respectively). Conclusions Our results identify that IL-10 promoter polymorphisms might not be a risk factor for PCa in Chinese cohorts, but rather incidence of polymorphisms associates with PCa grade, suggesting that IL-10 expression may impact PCa progression.
- Shandong Provincial Hospital China (People's Republic of)
- Affiliated Hospital of Taishan Medical University China (People's Republic of)
- Shandong Tumor Hospital China (People's Republic of)
Aged, 80 and over, Male, Cancer Research, Genotype, Prostate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Prognosis, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Interleukin-10, Oncology, Risk Factors, Case-Control Studies, Genetics, Humans, Promoter Regions, Genetic, RC254-282, Alleles, Research Article, Aged
Aged, 80 and over, Male, Cancer Research, Genotype, Prostate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Prognosis, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Interleukin-10, Oncology, Risk Factors, Case-Control Studies, Genetics, Humans, Promoter Regions, Genetic, RC254-282, Alleles, Research Article, Aged
17 Research products, page 1 of 2
- 2006IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2008IsAmongTopNSimilarDocuments
- 2011IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2011IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).37 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
